Search research articles
Contact Us
Filters
Showing results (11-20 of 22) with videos related to
Page
of 3
Sort By:
Journal of the American Society of Nephrology : JASN
|
April 10, 2015
Disease Severity Correlates with Thrombotic Capacity in Experimental Nephrotic Syndrome
Bryce A Kerlin, Amanda P Waller, Ruchika Sharma, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis
|
November 16, 2020
A pilot randomized trial of atorvastatin as adjunct therapy in patients with acute venous thromboembolism
Tzu-Fei Wang, Amanda P Waller, Ella Lin, et al.
Journal of Thrombosis and Haemostasis : JTH
|
October 19, 2025
Hypoalbuminemia increases fibrin clot density and impairs fibrinolysis
Amanda P Waller, Katelyn J Wolfgang, Zachary S Stevenson, et al.
Physiological Reports
|
August 11, 2020
Nephrotic syndrome-associated hypercoagulopathy is alleviated by both pioglitazone and glucocorticoid which target two different nuclear receptors
Amanda P Waller, Shipra Agrawal, Katelyn J Wolfgang, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
February 8, 2023
Exploring the Role of Antithrombin in Nephrotic Syndrome-Associated Hypercoagulopathy: A Multi-Cohort Study and Meta-Analysis
Eman Abdelghani, Amanda P Waller, Katelyn J Wolfgang, et al.
Journal of the American Society of Nephrology : JASN
|
April 21, 2017
Thrombin-Induced Podocyte Injury Is Protease-Activated Receptor Dependent
Ruchika Sharma, Amanda P Waller, Shipra Agrawal, et al.
Thrombosis Research
|
February 26, 2021
Nephrotic syndrome disease activity is proportional to its associated hypercoagulopathy
Amanda P Waller, Jonathan P Troost, Samir V Parikh, et al.
Iscience
|
January 8, 2024
Glucocorticoid- and pioglitazone-induced proteinuria reduction in experimental NS both correlate with glomerular ECM modulation
Sagar Bhayana, Julie A Dougherty, Yu Kamigaki, et al.
Iscience
|
March 21, 2022
Selective modulator of nuclear receptor PPARγ with reduced adipogenic potential ameliorates experimental nephrotic syndrome
Claire Bryant, Galen Rask, Amanda P Waller, et al.
BMC Nephrology
|
February 24, 2026
Voclosporin ameliorates proteinuria in a model of non-inflammatory glomerular disease
Yu Kamigaki, Julie A Dougherty, Amanda P Waller, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 22) with videos related to
Sort By:
Page
of 3
Journal of the American Society of Nephrology : JASN
|
April 10, 2015
Disease Severity Correlates with Thrombotic Capacity in Experimental Nephrotic Syndrome
Bryce A Kerlin, Amanda P Waller, Ruchika Sharma, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis
|
November 16, 2020
A pilot randomized trial of atorvastatin as adjunct therapy in patients with acute venous thromboembolism
Tzu-Fei Wang, Amanda P Waller, Ella Lin, et al.
Journal of Thrombosis and Haemostasis : JTH
|
October 19, 2025
Hypoalbuminemia increases fibrin clot density and impairs fibrinolysis
Amanda P Waller, Katelyn J Wolfgang, Zachary S Stevenson, et al.
Physiological Reports
|
August 11, 2020
Nephrotic syndrome-associated hypercoagulopathy is alleviated by both pioglitazone and glucocorticoid which target two different nuclear receptors
Amanda P Waller, Shipra Agrawal, Katelyn J Wolfgang, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
February 8, 2023
Exploring the Role of Antithrombin in Nephrotic Syndrome-Associated Hypercoagulopathy: A Multi-Cohort Study and Meta-Analysis
Eman Abdelghani, Amanda P Waller, Katelyn J Wolfgang, et al.
Journal of the American Society of Nephrology : JASN
|
April 21, 2017
Thrombin-Induced Podocyte Injury Is Protease-Activated Receptor Dependent
Ruchika Sharma, Amanda P Waller, Shipra Agrawal, et al.
Thrombosis Research
|
February 26, 2021
Nephrotic syndrome disease activity is proportional to its associated hypercoagulopathy
Amanda P Waller, Jonathan P Troost, Samir V Parikh, et al.
Iscience
|
January 8, 2024
Glucocorticoid- and pioglitazone-induced proteinuria reduction in experimental NS both correlate with glomerular ECM modulation
Sagar Bhayana, Julie A Dougherty, Yu Kamigaki, et al.
Iscience
|
March 21, 2022
Selective modulator of nuclear receptor PPARγ with reduced adipogenic potential ameliorates experimental nephrotic syndrome
Claire Bryant, Galen Rask, Amanda P Waller, et al.
BMC Nephrology
|
February 24, 2026
Voclosporin ameliorates proteinuria in a model of non-inflammatory glomerular disease
Yu Kamigaki, Julie A Dougherty, Amanda P Waller, et al.
Page
of 3